These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

911 related items for PubMed ID: 26741962

  • 1. Antimicrobial Activities of Methanol, Ethanol and Supercritical CO2 Extracts of Philippine Piper betle L. on Clinical Isolates of Gram Positive and Gram Negative Bacteria with Transferable Multiple Drug Resistance.
    Valle DL, Cabrera EC, Puzon JJ, Rivera WL.
    PLoS One; 2016; 11(1):e0146349. PubMed ID: 26741962
    [Abstract] [Full Text] [Related]

  • 2. Surveillance of tigecycline activity tested against clinical isolates from a global (North America, Europe, Latin America and Asia-Pacific) collection (2016).
    Pfaller MA, Huband MD, Streit JM, Flamm RK, Sader HS.
    Int J Antimicrob Agents; 2018 Jun; 51(6):848-853. PubMed ID: 29410368
    [Abstract] [Full Text] [Related]

  • 3. Antimicrobial susceptibility among gram-positive and gram-negative blood-borne pathogens collected between 2012-2016 as part of the Tigecycline Evaluation and Surveillance Trial.
    Zhang Z, Chen M, Yu Y, Pan S, Liu Y.
    Antimicrob Resist Infect Control; 2018 Jun; 7():152. PubMed ID: 30564308
    [Abstract] [Full Text] [Related]

  • 4. Oritavancin Combinations with β-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
    Smith JR, Yim J, Raut A, Rybak MJ.
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2352-8. PubMed ID: 26833159
    [Abstract] [Full Text] [Related]

  • 5. Investigation of Hungarian mushrooms for antibacterial activity and synergistic effects with standard antibiotics against resistant bacterial strains.
    Liktor-Busa E, Kovács B, Urbán E, Hohmann J, Ványolós A.
    Lett Appl Microbiol; 2016 Jun; 62(6):437-43. PubMed ID: 27100065
    [Abstract] [Full Text] [Related]

  • 6. The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016.
    Decousser JW, Woerther PL, Soussy CJ, Fines-Guyon M, Dowzicky MJ.
    Antimicrob Resist Infect Control; 2018 Jun; 7():68. PubMed ID: 29876099
    [Abstract] [Full Text] [Related]

  • 7. Antimicrobial susceptibility among Gram-positive and Gram-negative organisms collected from the Latin American region between 2004 and 2015 as part of the Tigecycline Evaluation and Surveillance Trial.
    Vega S, Dowzicky MJ.
    Ann Clin Microbiol Antimicrob; 2017 Jul 12; 16(1):50. PubMed ID: 28701170
    [Abstract] [Full Text] [Related]

  • 8. Antimicrobial efficacy and activity of ethanolic extract of Piper betle L. on Staphylococcus aureus-infected wound in mice and clinical isolates of multiple drug-resistant bacterial pathogens.
    Valle DLJ, Puzon JJM, Cabrera EC, Cena-Navarro RB, Rivera WL.
    Trop Biomed; 2021 Jun 01; 38(2):134-142. PubMed ID: 34172702
    [Abstract] [Full Text] [Related]

  • 9. In vitro activity of tigecycline and comparators (2014-2016) among key WHO 'priority pathogens' and longitudinal assessment (2004-2016) of antimicrobial resistance: a report from the T.E.S.T. study.
    Seifert H, Blondeau J, Dowzicky MJ.
    Int J Antimicrob Agents; 2018 Oct 01; 52(4):474-484. PubMed ID: 30012439
    [Abstract] [Full Text] [Related]

  • 10. Bacterial susceptibility in bloodstream infections: Results from China Antimicrobial Resistance Surveillance Trial (CARST) Program, 2015-2016.
    Zhang F, Li Y, Lv Y, Zheng B, Xue F.
    J Glob Antimicrob Resist; 2019 Jun 01; 17():276-282. PubMed ID: 30611932
    [Abstract] [Full Text] [Related]

  • 11. In vitro antibacterial activity of Quercus infectoria gall extracts against multidrug resistant bacteria.
    Wan Nor Amilah WA, Masrah M, Hasmah A, Noor Izani NJ.
    Trop Biomed; 2014 Dec 01; 31(4):680-8. PubMed ID: 25776593
    [Abstract] [Full Text] [Related]

  • 12. Trends in the susceptibility of clinically important resistant bacteria to tigecycline: results from the Tigecycline In Vitro Surveillance in Taiwan study, 2006 to 2010.
    Chen YH, Lu PL, Huang CH, Liao CH, Lu CT, Chuang YC, Tsao SM, Chen YS, Liu YC, Chen WY, Jang TN, Lin HC, Chen CM, Shi ZY, Pan SC, Yang JL, Kung HC, Liu CE, Cheng YJ, Liu JW, Sun W, Wang LS, Ko WC, Yu KW, Chiang PC, Lee MH, Lee CM, Hsu GJ, Hsueh PR.
    Antimicrob Agents Chemother; 2012 Mar 01; 56(3):1452-7. PubMed ID: 22203598
    [Abstract] [Full Text] [Related]

  • 13. Update on antimicrobial susceptibility rates among gram-negative and gram-positive organisms in the United States: results from the Tigecycline Evaluation and Surveillance Trial (TEST) 2005 to 2007.
    Dowzicky MJ, Park CH.
    Clin Ther; 2008 Nov 01; 30(11):2040-50. PubMed ID: 19108792
    [Abstract] [Full Text] [Related]

  • 14. Value of American Thoracic Society guidelines in predicting infection or colonization with multidrug-resistant organisms in critically ill patients.
    Xie J, Ma X, Huang Y, Mo M, Guo F, Yang Y, Qiu H.
    PLoS One; 2014 Nov 01; 9(3):e89687. PubMed ID: 24647408
    [Abstract] [Full Text] [Related]

  • 15. In Vitro Activities of Tedizolid and Linezolid against Gram-Positive Cocci Associated with Acute Bacterial Skin and Skin Structure Infections and Pneumonia.
    Chen KH, Huang YT, Liao CH, Sheng WH, Hsueh PR.
    Antimicrob Agents Chemother; 2015 Oct 01; 59(10):6262-5. PubMed ID: 26248355
    [Abstract] [Full Text] [Related]

  • 16. Drug resistance patterns of bacteria isolated from patients with nosocomial pneumonia at Tehran hospitals during 2009-2011.
    Haeili M, Ghodousi A, Nomanpour B, Omrani M, Feizabadi MM.
    J Infect Dev Ctries; 2013 Apr 17; 7(4):312-7. PubMed ID: 23592640
    [Abstract] [Full Text] [Related]

  • 17. In Vitro Activity of Plazomicin against Gram-Negative and Gram-Positive Isolates Collected from U.S. Hospitals and Comparative Activities of Aminoglycosides against Carbapenem-Resistant Enterobacteriaceae and Isolates Carrying Carbapenemase Genes.
    Castanheira M, Davis AP, Mendes RE, Serio AW, Krause KM, Flamm RK.
    Antimicrob Agents Chemother; 2018 Aug 17; 62(8):. PubMed ID: 29866862
    [Abstract] [Full Text] [Related]

  • 18. Antimicrobial activity of a UV-stable bacteriocin-like inhibitory substance (BLIS) produced by Enterococcus faecium strain DSH20 against vancomycin-resistant Enterococcus (VRE) strains.
    Shokri D, Zaghian S, Khodabakhsh F, Fazeli H, Mobasherizadeh S, Ataei B.
    J Microbiol Immunol Infect; 2014 Oct 17; 47(5):371-6. PubMed ID: 23838264
    [Abstract] [Full Text] [Related]

  • 19. Histone H5 is a potent Antimicrobial Agent and a template for novel Antimicrobial Peptides.
    Jodoin J, Hincke MT.
    Sci Rep; 2018 Feb 05; 8(1):2411. PubMed ID: 29402952
    [Abstract] [Full Text] [Related]

  • 20. Antimicrobial susceptibility trends among gram-positive and -negative clinical isolates collected between 2005 and 2012 in Mexico: results from the Tigecycline Evaluation and Surveillance Trial.
    Morfin-Otero R, Noriega ER, Dowzicky MJ.
    Ann Clin Microbiol Antimicrob; 2015 Dec 15; 14():53. PubMed ID: 26667651
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.